ChIPseq_LNCaP-siNON_p65_TNFa_rep1
Homo sapiens
source_name
prostate cancer
cell line
LNCaP
treatment 1
TNF-alpha (1000 U/ml, 2h)
treatment 2
control siRNA transfection
antibody
anti-p65 (Santa Cruz Biotechnology, sc-372)